BackCaladrius Biosciences Overview

Caladrius Biosciences Total Assets

Track Caladrius Biosciences's total assets ($650M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$648.41M
↑ 2879.96% YoYΔ $626.65M vs prior year quarter

Peer trimmed avg / median

Loading

Caladrius Biosciences Total Assets History

Loading

Caladrius Biosciences vs. peers: Total Assets Comparison

Loading

Caladrius Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Caladrius Biosciences (CLBS) FAQ

Caladrius Biosciences's total assets stands at $650M as of September 2026. That compares with $22M in the prior-year period — up 2880.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Caladrius Biosciences reported $650M in total assets versus $22M a year earlier — a 2880.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $22M in the prior-year period — up 2880.0% year over year. Sustained growth in total assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Caladrius Biosciences's total assets evolved across reporting periods, while the comparison chart places CLBS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total assets is commonly used to spot outliers. Caladrius Biosciences's reading of $650M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.